232 In vitro and in vivo antitumor efficacy of NCX-4040, a nitric oxide-releasing non-steroidal anti-inflammatory drug, in combination with antineoplastic drugs on human colon cancer lines

  • C. Leonetti, M. Scarsella, G. Zupi, W. Zoli, D. Amadori, P. Ulivi, F. Fabbri, M. Bolla, R. Maucci, A. Tesei
  • European Journal of Cancer Supplements, September 2004, Elsevier
  • DOI: 10.1016/s1359-6349(04)80240-4

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Anna Tesei